The CIt protocol: A blueprint to potentiate the immunogenicity of immunoproteasome-reprogrammed mesenchymal stromal cells

Immunoproteasome-reprogrammed mesenchymal stromal cells (IRMs) can surpass dendritic cells at eliciting tumor-specific immunity. However, the current IRM vaccination regimen remains clinically unsuitable due to the relatively high dose of IRMs needed. Since the administration of a lower IRM dose tri...

Descripción completa

Detalles Bibliográficos
Autores principales: Bikorimana, Jean-Pierre, El-Hachem, Nehme, Abusarah, Jamilah, Eliopoulos, Nicoletta, Talbot, Sebastien, Shammaa, Riam, Rafei, Moutih
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682353/
https://www.ncbi.nlm.nih.gov/pubmed/36437872
http://dx.doi.org/10.1016/j.isci.2022.105537

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682353/
https://www.ncbi.nlm.nih.gov/pubmed/36437872
http://dx.doi.org/10.1016/j.isci.2022.105537

Ejemplares similares